US 8052970
Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
granted A61KA61K38/45A61K38/465
Quick answer
US patent 8052970 (Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/45, A61K38/465, A61P, A61P11/00